"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(VAY-so-PRESS-in)
Pitressin Synthetic
Class: Posterior pituitary hormone

 Action Promotes resorption of water through kidney. At high doses, stimulates contraction of smooth muscle causing vasoconstriction, increased peristaltic activity, and gall-bladder contractions.

 Indications Treatment of neurogenic diabetes insipidus; prevention and treatment of postoperative abdominal distention; facilitation of abdominal roentgenography.

Treatment of bleeding esophageal varices.

 Contraindications Standard considerations.

 Route/Dosage

Diabetes Insipidus

ADULTS & CHILDREN: IM/SC 2.5 to 10 units 2 to 4 times daily as needed.

Abdominal Distention

ADULTS: IM 5 units initially; subsequent injections q 3 to 4 hr prn. May increase the dose to 10 units if necessary.

Abdominal Roentgenography

ADULTS: IM/SC 2 injections of 10 units each administered 2 hr and 30 min before films are exposed.

Bleeding Esophageal Varices

ADULTS: IV Infuse initially at 0.2 to 0.4 U/min and increase to 0.9 U/min if necessary.

 Interactions

Carbamazepine, chlorpropamide: May potentiate antidiuretic effect of vasopressin.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: ANGINA. GI: Abdominal cramps; nausea; vomiting; gas. OTHER: Gangrene; ischemic colitis; tissue necrosis (with extravasation); allergic reaction (cardiac arrest, tremor, vertigo, sweating).

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Special risk patients: Use drug with caution in patients with epilepsy, migraine, asthma, heart failure, or any condition where a rapid rise in extracellular water may result in further compromise. Chronic nephritis with nitrogen retention: Contraindicates use until reasonable nitrogen blood levels have been attained. Extravasation: Severe vasoconstriction and local tissue necrosis may result if drug extravasates during IV infusion. Hypersensitivity: Local or systemic reactions, including anaphylaxis, may occur. Vascular disease: Use extreme caution in patients with vascular disease. Water intoxication: May occur. Early signs include confusion, drowsiness, listlessness, and headache.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Store at room temperature. Do not freeze.
  • Give 1 to 2 glasses of water with dose to prevent skin blanching, abdominal cramps, and nausea.
  • If administering via IV infusion, 0.9% Normal Saline or D5W to a concentration of 0.1 to 1 U/ml. Insure patency of venous access and use infusion control device.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Monitor for allergic reactions, including tremor, sweating, vertigo, circumoral pallor, “pounding in head,” abdominal cramps, flatus, nausea, vomiting, urticaria, bronchial constriction.
  • Monitor I & O, and weigh daily.
  • Monitor urine specific gravity and osmolarity.
  • Monitor vital signs.
  • Monitor ECG and fluid and electrolyte status at frequent intervals during prolonged therapy.
  • Monitor patient for evidence of water intoxication (confusion, drowsiness, listlessness, headache). Report to health care provider immediately if noted.
  • Monitor for therapeutic response: Decreased urine output;decreased thirst.
  • Assess reduction of thirst.
  • In abdominal distention, assess bowel sounds and presence or absence of flatus.
OVERDOSAGE: SIGNS & SYMPTOMS
  Confusion, lethargy, drowsiness, listlessness, headache

 Patient/Family Education

  • Tell patient to take with 1 to 2 glasses of water to prevent skin blanching, nausea, abdominal cramping.
  • Caution patient to withhold medication and to notify health care provider of chest pain.
  • Tell patient to report drowsiness, listlessness, and headache to health care provider and to restrict water intake.
  • Explain that urine output should decrease after use.
  • Tell patient to monitor weight daily.
  • Instruct patient to avoid alcohol intake during therapy.
  • Remind patients with diabetes insipidus to carry appropriate medical identification.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below